| Autor: |
Sigetti, D., Jenkins, F.S., Hettlich, V.H., Boettger, C.S., Dalyanoglu, H., Tokhi, U., Voß, F., Scheiber, D., Aubin, H., Lichtenberg, A., Boeken, U. |
| Předmět: |
|
| Zdroj: |
Thoracic & Cardiovascular Surgeon; 2024 Supplement1, Vol. 72, pS1-S68, 68p |
| Abstrakt: |
This article discusses the incidence and risk factors for malignancies in patients who have undergone heart transplantation at a single center. The study analyzed data from 296 patients who had undergone heart transplantation between September 2010 and August 2023. The overall incidence of malignancy was 8.8%, with skin cancer being the most common type. The study found that the switch to everolimus as part of the immunosuppression therapy did not reduce the incidence of malignancies. Early detection through close follow-up is important for improving the prognosis of these malignancies. [Extracted from the article] |
| Databáze: |
Complementary Index |
| Externí odkaz: |
|
